phosphodiesterase 7B (PDE7B) (Middle Region) Peptide
PDE7B
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits PDE7B
- PDE7B (phosphodiesterase 7B (PDE7B))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-PDE7B antibody (Catalog #: ARP55364_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- PDE7B (phosphodiesterase 7B (PDE7B))
- Synonymes
- PDE7B Peptide, ba472e5.1 Peptide, bA472E5.1 Peptide, phosphodiesterase 7B Peptide, PDE7B Peptide, pde7b Peptide, Pde7b Peptide
- Sujet
-
The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates a
Alias Symbols: MGC88256, bA472E5.1
Protein Size: 450 - Poids moléculaire
- 52 kDa
- ID gène
- 27115
- NCBI Accession
- NM_018945, NP_061818
- UniProt
- Q9NP56
-
Vous êtes ici:
